Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 9,617,000 | 9,498,075 | 9,019,827 | 8,512,271 | 9,319,333 |
| Cost of Goods | 3,859,740 | 3,417,300 | 3,070,850 | 3,188,350 | 3,229,649 |
| Gross Profit | 5,677,068 | 6,082,610 | 5,947,200 | 5,335,150 | 6,602,299 |
| Operating Expenses | -7,603,240 | 4,647,140 | 5,529,910 | 4,688,120 | 6,147,828 |
| Operating Income | 13,361,240 | 1,433,935 | 419,917 | 636,151 | -57,495 |
| Interest Expense | 302,520 | 268,230 | 297,130 | 289,570 | 299,930 |
| Other Income | -13,585,810 | 178,575 | 110,013 | 14,697,679 | 1,179,215 |
| Pre-tax Income | -527,090 | 1,344,280 | 232,800 | 15,044,260 | 821,790 |
| Income Tax | 37,850 | 341,110 | 56,660 | 2,857,840 | -829,110 |
| Net Income Continuous | -541,000 | 834,008 | 228,253 | 12,247,550 | 1,556,235 |
| Net Income | $-541,000 | $834,008 | $228,253 | $12,247,550 | $1,556,235 |
| EPS Basic Total Ops | -0.28 | 0.43 | 0.11 | 6.35 | 0.81 |
| EPS Basic Continuous Ops | -0.28 | 0.43 | 0.12 | 6.35 | 0.81 |
| EPS Diluted Total Ops | -0.28 | 0.43 | 0.11 | 6.30 | 0.80 |
| EPS Diluted Continuous Ops | -0.28 | 0.43 | 0.12 | 6.35 | 0.81 |
| EBITDA(a) | $13,766,540 | $3,349,375 | $60,817 | $1,166,781 | $1,060,805 |